DIMETHICONE DOES NOT ALTER THE PHARMACOKINETICS OF CONCOMITANTLY ADMINISTERED ORAL CIMETIDINE IN HEALTHY MAN

被引：0
|
作者：
ENTERLING, D [1 ]
DEMEY, C [1 ]
BRENDEL, E [1 ]
WESCHE, H [1 ]
机构：
[1] SK&F,INST APPL CLIN PHARMACOL,D-3400 GOTTINGEN,FED REP GER
来源：
THERAPIE | 1988年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [41] Zonisamide does not affect the pharmacokinetics or pharmacodynamics of an oral contraceptive in healthy females
    Cloyd, JC
    Dai, YQ
    [J]. NEUROLOGY, 2005, 64 (06) : A115 - A115
  • [42] Concurrent administration of omeprazole and antacid does not alter the pharmacokinetics and pharmacodynamics of dofetilide in healthy subjects.
    Vincent, J
    Gardner, MJ
    Baris, B
    Willavize, SA
    Pfizer, CR
    Groton, CT
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII93 - PII93
  • [43] Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects
    Andrews, Emma
    Damle, Bharat D.
    Fang, Annie
    Foster, Grover
    Crownover, Penelope
    LaBadie, Robert
    Glue, Paul
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (04) : 531 - 539
  • [44] EVALUATE THE EFFECT OF ORAL DOSES OF IBREXAFUNGERP ON THE PHARMACOKINETICS OF DABIGATRAN ADMINISTERED ORALLY TO HEALTHY SUBJECTS.
    Azie, N.
    Angulo, D.
    Wabnitz, P.
    Murphy, G.
    Ghahramani, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [45] ORAL DIET DOES NOT ALTER PULMONARY PENTANE OR ETHANE EXCRETION IN HEALTHY-SUBJECTS
    ZARLING, EJ
    MOBARHAN, S
    BOWEN, P
    SUGERMAN, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1992, 11 (03) : 349 - 352
  • [46] Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers
    Bavato, Francesco
    Schnider, Laura K.
    Dornbierer, Dario A.
    Seifritz, Erich
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (09) : 942 - 944
  • [47] The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel
    van Zuylen, L
    Sparreboom, A
    van der Gaast, A
    van der Burg, MEL
    van Beurden, V
    Bol, CJ
    Woestenborghs, R
    Palmer, PA
    Verweij, J
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (04) : 1365 - 1371
  • [48] An open-label study on the pharmacokinetics (PK) of pitavastatin (NK-104) when administered concomitantly with fenofibrate or gemfibrozil in healthy volunteers.
    Mathew, P
    Cuddy, T
    Tracewell, WG
    Salazar, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P33 - P33
  • [49] Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects
    Patel, C. G.
    Kornhauser, D.
    Vachharajani, N.
    Komoroski, B.
    Brenner, E.
    del Corral, M. Handschuh
    Li, L.
    Boulton, D. W.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 604 - 614
  • [50] LINAGLIPTIN, A NOVEL ONCE-DAILY ORAL DPP-4 INHIBITOR, DOES NOT ALTER THE PLASMA PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN IN HEALTHY VOLUNTEERS.
    Graefe-Mody, U.
    Brand, T.
    Ring, A.
    Gaebler, D.
    Withopf, B.
    Stangier, J.
    Iovino, M.
    Woerle, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S30 - S30
12345